Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyDevoted Health Cardiac Ablation Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentDevoted HealthPolicy UMGT.CL.0059

    Electrophysiology Testing and Cardiac Catheter Ablation

    Customize your policy alerts

    Sign up for devoted_health Policy UMGT.CL.0059 alerts

    Get alerted when Policy UMGT.CL.0059 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of electrophysiology testing, including testing with or without 3D mapping, and cardiac radiofrequency or cryothermal ablation for Devoted Health Medicare Advantage members in MAC jurisdictions without an applicable LCD, when criteria for a specified arrhythmia or clinical scenario are met.

    Policy Summary
    PayerDevoted Health
    PolicyElectrophysiology Testing and Cardiac Catheter Ablation
    Policy CodePolicy UMGT.CL.0059
    Change TypeAdditional clinical criteria
    Effective DateApril 30, 2026
    Next Review DateApril 15, 2027
    Key ActionSubmit ECG documentation identifying the arrhythmia or suspected arrhythmia, relevant symptoms, ejection fraction when applicable, prior ablation history, and support for the applicable coverage scenario.
    SourceLink
    POLICY UPDATE CHANGES

    Additional clinical criteria were added in version 1.1.

    Criteria for electrophysiology study testing were added in version 2.0.

    9

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Clinical coverage scenarios listed
    EF ≤40%Heart-failure EF threshold
    ≥8 weeksPost-ablation recurrence interval
    13Applicable CPT codes
    MAC-basedApplicability structure

    Covered Clinical Scenarios

    Atrial fibrillation

    Covered when all applicable criteria are met.

    ALL of the following

    • Diagnosis: Atrial fibrillation documented by electrocardiogram (ECG)
    • Qualifying pathway

      • Symptomatic AF pathway: Symptomatic paroxysmal or persistent atrial fibrillation as first-line therapy
      • Heart-failure pathway: Evidence of heart failure with documented ejection fraction and criteria for one of the atrial-fibrillation heart-failure scenarios

        See the atrial fibrillation with heart failure criteria.

    Atrial flutter

    Covered when all applicable criteria are met.

    ALL of the following

    • Diagnosis: Atrial flutter documented by electrocardiogram (ECG)
    • Qualifying finding

      • Symptoms or cardiac finding: Presyncope or syncope by history; palpitations; chest pain or discomfort; dyspnea; dizziness; fatigue; or decreased ejection fraction

    Preexcitation or Wolff-Parkinson-White syndrome

    Covered when the diagnosis is documented.

    ALL of the following

    • Diagnosis: Preexcitation syndrome or Wolff-Parkinson-White (WPW) syndrome documented by electrocardiogram (ECG)

    Atrial fibrillation with heart failure

    Covered when all criteria in one heart-failure pathway are met.

    Heart-failure pathway

    • EF ≤40% pathway

      • Heart failure with ejection fraction (EF) ≤40%EF ≤ 40%
      • Evidence the member has not tolerated guideline-directed medical therapy (GDMT) for heart failure
      • Atrial-fibrillation criterion

        • Paroxysmal atrial fibrillation
        • Persistent or long-standing atrial fibrillation

    AVNRT, AVRT, or focal atrial tachycardia

    Covered when the suspected arrhythmia and all associated clinical criteria are documented.

    ALL of the following

    • Suspected arrhythmia

      • Suspected atrioventricular nodal reentrant tachycardia (AVNRT) by electrocardiogram (ECG)
      • Suspected atrioventricular reentrant tachycardia (AVRT) by electrocardiogram (ECG)
      • Suspected focal atrial tachycardia by electrocardiogram (ECG)
    • Ablation history pathway

      • Symptomatic atrial tachyarrhythmia and no history of ablation

    Focal atrial tachycardia

    Covered when all criteria are met.

    ALL of the following

    • Suspected focal atrial tachycardia by electrocardiogram (ECG)
    • Ablation history pathway

      • Recurrent symptomatic atrial tachyarrhythmia and no history of ablation
      • Recurrent symptomatic atrial tachyarrhythmia after ablation
    • Qualifying symptom

      • Presyncope or syncope by history

    Frequent monomorphic premature ventricular complexes

    Covered when all criteria for either the no-prior-ablation or post-ablation pathway are met.

    ALL of the following

    • Frequent monomorphic premature ventricular complexes (PVCs) documented by electrocardiogram (ECG)
    • Treatment pathway

      • No-prior-ablation pathway

        • No history of ablation
        • Qualifying symptom or cardiac finding

          • Presyncope or syncope by history
          • Palpitations

    Nonsustained ventricular tachycardia

    Covered when all criteria for either the no-prior-ablation or post-ablation pathway are met.

    ALL of the following

    • Nonsustained ventricular tachycardia (VT) documented by electrocardiogram (ECG)
    • Treatment pathway

      • No-prior-ablation pathway

        • No history of ablation
        • Qualifying symptom or cardiac finding

          • Presyncope or syncope by history
          • Palpitations

    Sustained ventricular tachycardia

    Covered when either ablation pathway and the coronary artery disease evaluation requirement are met.

    ALL of the following

    • Sustained ventricular tachycardia (VT) documented by electrocardiogram (ECG)
    • Ablation pathway

      • No history of ablation
      • Tachycardia after ablation
    • Coronary artery disease evaluation result

      • No evidence of coronary artery disease (CAD)

    Presyncope or syncope

    Covered when all criteria are met.

    ALL of the following

    • Presyncope or syncope by history
    • Qualifying cardiac, inherited-risk, symptom, or clinical finding

      • Congenital heart disease or structural heart disease documented by transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE)
      • Coronary artery disease by history
      • Hypertrophic cardiomyopathy by testing

        Urgent finding.

      • Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) by testing

    Coding and Clinical Thresholds

    Covered CPT CodesCPTCovered
    93660Bundle of His recording
    93602Intra-atrial recording
    93603Intra-atrial recording
    93609Intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia (list separately in addition to code for primary procedure) (w/93620, 93653, 93656)
    93610Intra-atrial pacing
    93612Intraventricular pacing
    93613Intracardiac electrophysiologic 3-dimensional mapping (list separately in addition to code for primary procedure) (w/93620)
    93618Induction of arrhythmia by electrical pacing
    93619Comprehensive electrophysiology evaluation with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording, including insertion and repositioning of multiple electrode catheters, without induction or attempted induction of arrhythmia
    93620Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording
    1–10 of 17
    1/2
    Heart failure with reduced ejection fraction
    Ejection fraction thresholdEF ≤ 40%
    Heart-failure requirementHeart failure with documented ejection fraction
    Additional treatment requirementEvidence the member has not tolerated guideline-directed medical therapy (GDMT) for heart failure
    Heart failure with EF above 40%
    Ejection fraction thresholdEF > 40%
    Atrial-fibrillation requirementParoxysmal, persistent, or long-standing atrial fibrillation, or recurrence after ablation of at least 8 weeks

    Documentation and Denial Risks

    Documentation Required

    Document the arrhythmia and clinical findings

    Submit ECG documentation identifying the arrhythmia or suspected arrhythmia, along with relevant symptoms, ejection fraction when applicable, prior ablation history, and clinical documentation supporting the applicable coverage scenario.

    Documentation Required

    Document EF and medication history

    For heart-failure, PVC, or nonsustained VT criteria, document the ejection fraction and the member’s tolerance or contraindication of guideline-directed or anti-arrhythmic medication, as applicable. Include the applicable recurrence or treatment history.

    • Heart-failure pathways require documentation of EF ≤ 40% or EF > 40%, as applicable.
    • Document whether guideline-directed medical therapy was not tolerated or whether anti-arrhythmic medication was contraindicated, not tolerated, continued despite arrhythmia, or not desired.
    • Document recurrence after ablation when that pathway applies.

    Policy Scope

    This policy outlines coverage for electrophysiology (EP) testing, including testing with or without three-dimensional mapping, and cardiac catheter ablation using radiofrequency or cryothermal energy. It applies to Devoted Health Medicare Advantage members in applicable MAC jurisdictions without an applicable Local Coverage Determination (LCD).

    The services address symptomatic atrial and ventricular arrhythmias, including atrial fibrillation, atrial flutter, supraventricular tachycardias, ventricular ectopy, and ventricular tachycardia. Catheter ablation is a primary non-pharmacologic treatment for many symptomatic arrhythmias that are resistant to anti-arrhythmic therapy or may adversely affect cardiac function; for atrial fibrillation, treatment generally targets pulmonary-vein isolation and/or modification of the left-atrial substrate. Coverage requires the member to meet all applicable criteria for at least one specified clinical scenario.

    Key Terms

    EP testing
    TermEP testing
    MeaningElectrophysiology testing
    Mapping optionIncludes EP testing with or without three-dimensional (3D) mapping
    LCD
    AbbreviationLCD
    Full termLocal Coverage Determinations
    Glossary categoryAcronym and definition used in the policy
    Policy Summary
    PayerDevoted Health
    PolicyElectrophysiology Testing and Cardiac Catheter Ablation
    Policy CodePolicy UMGT.CL.0059
    Change TypeAdditional clinical criteria
    Effective DateApril 30, 2026
    Next Review DateApril 15, 2027
    Key ActionSubmit ECG documentation identifying the arrhythmia or suspected arrhythmia, relevant symptoms, ejection fraction when applicable, prior ablation history, and support for the applicable coverage scenario.
    SourceLink
    On This Page
    Covered Clinical ScenariosCoding and Clinical ThresholdsDocumentation and Denial RisksPolicy ScopeKey Terms
  1. Recurrence after ablation≥ 8 weeks
  2. EF >40% pathway

    • Heart failure with ejection fraction (EF) >40%EF > 40%
    • Atrial-fibrillation criterion

      • Paroxysmal atrial fibrillation
      • Persistent or long-standing atrial fibrillation
      • Recurrence after ablation≥ 8 weeks
    • Qualifying symptom

      • Presyncope or syncope by history
      • Palpitations
      • Chest pain or discomfort
      • Dyspnea
      • Dizziness
  3. Recurrent symptomatic atrial tachyarrhythmia after ablation
  4. Qualifying symptom

    • Presyncope or syncope by history
    • Palpitations
    • Chest pain or discomfort
    • Dyspnea
    • Dizziness
    • Fatigue
  5. Palpitations
  6. Chest pain or discomfort
  7. Dyspnea
  8. Dizziness
  9. Fatigue
  10. Chest pain or discomfort
  11. Dyspnea
  12. Dizziness
  13. Fatigue
  14. Ejection fraction (EF) ≤40%EF ≤ 40%
  15. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) by testing
  16. Medication criterion

    • Recurrent or continued arrhythmia on anti-arrhythmic medication
    • Anti-arrhythmic medication is contraindicated or not tolerated
    • Long-term anti-arrhythmic medication is not desired
  17. Post-ablation pathway

    • Documented recurrence after ablation
    • Coronary artery disease evaluation result

      • No evidence of coronary artery disease (CAD)
      • Stenosis not significant enough to warrant revascularization
      • Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) with no new or recurrent ischemia
      • CAD not amenable to revascularization
  18. Chest pain or discomfort
  19. Dyspnea
  20. Dizziness
  21. Fatigue
  22. Ejection fraction (EF) ≤40%EF ≤ 40%
  23. Post-ablation pathway

    • Documentation of tachycardia after ablation
    • Coronary artery disease evaluation result

      • No evidence of coronary artery disease (CAD)
      • Stenosis not significant enough to warrant revascularization
      • Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) with no new or recurrent ischemia
      • CAD not amenable to revascularization
  24. Stenosis not significant enough to warrant revascularization
  25. Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) with no new or recurrent ischemia
  26. CAD not amenable to revascularization
  27. Urgent finding.

  28. Palpitations preceding syncope
  29. Family history of sudden cardiac death or an inheritable condition affecting cardiac function
  30. Ejection fraction (EF) ≤40%EF ≤ 40%
  31. Syncope during exertion or when supine
  32. Brief or absent prodrome (unheralded syncope)
  33. Syncope after ventricular tachycardia (VT) treatment
  34. Clinical documentation shows the member has not undergone noninvasive cardiac rhythm testing diagnostic for arrhythmia
  35. Additional clinical finding
    At least one of presyncope or syncope, palpitations, chest pain or discomfort, dyspnea, or dizziness
    Post-ablation recurrence
    Minimum interval≥ 8 weeks
    Applies toRecurrence of atrial fibrillation after ablation
    Qualifying pathwaysUsed in both the EF ≤ 40% and EF > 40% heart-failure pathways
    Documentation Required

    Include the coronary evaluation

    For ventricular tachycardia or recurrent ventricular arrhythmia after ablation, document the coronary artery disease evaluation and its result. The evaluation must support one of the policy’s qualifying findings regarding CAD or ischemia.

    • No evidence of coronary artery disease.
    • Stenosis not significant enough to warrant revascularization.
    • Prior PCI or CABG with no new or recurrent ischemia.
    • Coronary artery disease not amenable to revascularization.
    Documentation Required

    Complete the syncope documentation

    For presyncope or syncope, document the qualifying structural, ischemic, cardiomyopathic, inherited, symptom, EF, exertional, or post-treatment finding and confirm that diagnostic noninvasive rhythm testing has not already been performed.

    • Document congenital or structural heart disease by TTE or TEE, CAD by history, hypertrophic cardiomyopathy or ARVD/C by testing, or a family history of sudden cardiac death or an inheritable condition affecting cardiac function.
    • Document palpitations preceding syncope, EF ≤ 40%, syncope during exertion or when supine, brief or absent prodrome, or syncope after VT treatment, as applicable.
    • Document that the member has NOT undergone non-invasive cardiac rhythm testing diagnostic for arrhythmia.
    Denial Risk

    Ensure one complete coverage pathway is met

    Coverage may be denied when the member does not meet all criteria for at least one listed clinical scenario. The submission should include the required ECG or testing evidence, symptoms, prior-ablation status, medication history, coronary artery disease evaluation, and noninvasive rhythm-testing history applicable to the scenario.

    Denial Risk

    Do not omit the required syncope workup

    For presyncope or syncope coverage, documentation must show qualifying cardiac or inherited-risk findings and that the member has not undergone noninvasive cardiac rhythm testing diagnostic for arrhythmia. Missing either the qualifying finding or the required testing history may result in denial.

    Denial Risk

    Support post-ablation VT with CAD evaluation

    For ventricular arrhythmia scenarios after ablation, the record must include a coronary artery disease evaluation showing no CAD, stenosis not significant enough to warrant revascularization, prior PCI or CABG with no new or recurrent ischemia, or CAD not amenable to revascularization. An absent or inadequate CAD evaluation may result in denial.

    CMS
    AbbreviationCMS
    Full termCenters for Medicare and Medicaid Services
    Glossary categoryAcronym and definition used in the policy
    UM
    AbbreviationUM
    Full termUtilization Management
    Glossary categoryAcronym and definition used in the policy